Search Within

Shigehisa Kitano

  1. "Center for Hematologic Malignancies"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (3)
Groups
  1. Center for Hematologic Malignancies (7)
  2. Department of Medicine (7)
  3. GSK Faculty (7)
  4. Hematologic Malignancies Research (7)
  5. Hematologic Malignancies, Division of (7)
  6. Melanoma and Immunotherapeutics Service (7)

More Groups

People
  1. Alexander Lesokhin (7)
  2. Jedd Wolchok (7)
  3. Jianda Yuan (6)
  4. Margaret Callahan (3)
  5. Michael Postow (3)
  6. Alan Houghton (2)

More People

Years
  1. 2014 (1)
  2. 2013 (2)
  3. 2012 (4)
Publications
  1. Journal of Clinical Oncology (2)
  2. Cancer Research (1)
  3. Journal for ImmunoTherapy of Cancer (1)
  4. Journal of Experimental Medicine (1)
  5. Methods in Molecular Biology (1)
  6. New England Journal of Medicine (1)
Publishers
  1. American Society of Clinical Oncology (2)
  2. American Association for Cancer Research (1)
  3. Biomed Central Ltd (1)
  4. Humana Press Inc (1)
  5. Massachusetts Medical Society (1)
  6. Rockefeller University Press (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Markers for anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) therapy in melanoma
    Journal Article

    Postow, M. A.; Yuan, J.; Kitano, S.; Lesokhin, A. M.; Wolchok, J. D.
    Methods in Molecular Biology (2014)

    Fulltext@MSK | Save
  • Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab
    Meeting Abstract

    Callahan, M. K.; Horak, C. E.; Curran, M. A.; Hollman, T.; Schaer, D. A.; Yuan, J.; Lesokhin, A. M.; Kitano, S.; Hong, Q.; Ariyan, C. E.; more...
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Peripheral and tumor immune correlates in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab
    Meeting Abstract

    Callahan, M. K.; Horak, C. E.; Curran, M. A.; Hollman, T.; Schaer, D. A.; Yuan, J.; Lesokhin, A. M.; Kitano, S.; Hong, Q.; Ariyan, C. E.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Myeloid-derived suppressor cell quantity prior to treatment with ipilimumab at 10mg/kg to predict for overall survival in patients with metastatic melanoma
    Meeting Abstract

    Kitano, S.; Postow, M. A.; Cortez, C.; Rasalan, T.; Gallardo, H. F.; Panageas, K.; Yuan, J.; Wolchok, J. D.; Lesokhin, A. M.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype
    Journal Article

    Hirschhorn-Cymerman, D.; Budhu, S.; Kitano, S.; Liu, C.; Zhao, F.; Zhong, H.; Lesokhin, A. M.; Avogadri Connors, F.; Yuan, J.; Li, Y.; more...
    Journal of Experimental Medicine (2012)

    Fulltext@MSK | Save
  • Immunologic correlates of the abscopal effect in a patient with melanoma
    Journal Article

    Postow, M. A.; Callahan, M. K.; Barker, C. A.; Yamada, Y.; Yuan, J.; Kitano, S.; Mu, Z.; Rasalan, T.; Adamow, M.; Ritter, E.; more...
    New England Journal of Medicine (2012)

    Fulltext@MSK | Save
  • Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment
    Journal Article

    Lesokhin, A. M.; Hohl, T. M.; Kitano, S.; Cortez, C.; Hirschhorn-Cymerman, D.; Avogadri, F.; Rizzuto, G. A.; Lazarus, J. J.; Pamer, E. G.; Houghton, A. N.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save